3billion recently presented its AI-driven genetic testing services at the European Human Genetics Conference in Gothenburg. This international event serves as a major hub for geneticists and clinicians to share research and discuss advancements in the field.
The company showcased its growing service range, moving from rare disease diagnostics into broader areas like family-based genomic testing and newborn screening. The team introduced attendees to Family Insight and 3B-NEO, which aim to assist in early risk detection and long-term health management.
Participation in this conference allowed the 3billion leadership to hear directly from healthcare professionals about the infrastructure gaps and diagnostic challenges currently affecting international systems. These conversations provided feedback on how genomic technology can better serve local healthcare environments across the globe.
CEO Changwon Keum stated that the company remains focused on expanding its reach beyond diagnosis into prevention. 3billion intends to continue building solutions that support patients at every stage of life by integrating AI into their existing testing framework.